tiprankstipranks
Advertisement
Advertisement
Greenwich LifeSciences provides update on 10-K filing
PremiumThe FlyGreenwich LifeSciences provides update on 10-K filing
2M ago
Greenwich LifeSciences says Form 10-K ‘still being audited’
Premium
The Fly
Greenwich LifeSciences says Form 10-K ‘still being audited’
3M ago
Greenwich LifeSciences receives noncompliance notification from Nasdaq
Premium
The Fly
Greenwich LifeSciences receives noncompliance notification from Nasdaq
3M ago
Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial
PremiumThe FlyGreenwich LifeSciences adds City of Hope to FLAMINGO-01 trial
4M ago
Greenwich LifeSciences provides update on presentations at AACR Meeting 2026
Premium
The Fly
Greenwich LifeSciences provides update on presentations at AACR Meeting 2026
4M ago
Greenwich LifeSciences’ GLSI-100 reduces recurrence rate in Phase 3 trial
Premium
The Fly
Greenwich LifeSciences’ GLSI-100 reduces recurrence rate in Phase 3 trial
4M ago
Greenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
PremiumThe FlyGreenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
6M ago
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
Premium
Ratings
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
7M ago
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
Premium
The Fly
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100